Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Volin

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 1991
Serum amyloid A levels in acute graft-versus-host disease in bone marrow transplant recipientsR Leskinen, C P Maury, A M Teppo, et al.
Bone Marrow Transplantation|June 1, 1996
Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantationO Lyytikäinen, T Ruutu, L Volin, et al.
Bone Marrow Transplantation|March 13, 2001
Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipientsT Parkkali, H Käyhty, H Lehtonen, et al.
Bone Marrow Transplantation|July 1, 1996
Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantationE Jantunen, E Kolho, P Ruutu, et al.
Bone Marrow Transplantation|November 2, 2004
Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxisE Jantunen, A Nihtinen, L Volin, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 24, 2010
Factors influencing the performance level of Candida mannan antigen testing in allogeneic stem cell transplant recipients not receiving fluconazole prophylaxisA Nihtinen, V-J Anttila, M Richardson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2007
Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipientsS M Aalto, E Juvonen, J Tarkkanen, et al.
Bone Marrow Transplantation|May 1, 1997
A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMTT Parkkali, R M Olander, T Ruutu, et al.
Bone Marrow Transplantation|May 16, 2000
Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipientsE Jantunen, A Piilonen, L Volin, et al.
Bone Marrow Transplantation|July 21, 2009
Invasive Aspergillus infections in allo-SCT recipients: environmental sampling, nasal and oral colonization and galactomannan testingA Nihtinen, V-J Anttila, M Richardson, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 1991
Serum amyloid A levels in acute graft-versus-host disease in bone marrow transplant recipientsR Leskinen, C P Maury, A M Teppo, et al.
Bone Marrow Transplantation|June 1, 1996
Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantationO Lyytikäinen, T Ruutu, L Volin, et al.
Bone Marrow Transplantation|March 13, 2001
Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipientsT Parkkali, H Käyhty, H Lehtonen, et al.
Bone Marrow Transplantation|July 1, 1996
Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantationE Jantunen, E Kolho, P Ruutu, et al.
Bone Marrow Transplantation|November 2, 2004
Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxisE Jantunen, A Nihtinen, L Volin, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 24, 2010
Factors influencing the performance level of Candida mannan antigen testing in allogeneic stem cell transplant recipients not receiving fluconazole prophylaxisA Nihtinen, V-J Anttila, M Richardson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2007
Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipientsS M Aalto, E Juvonen, J Tarkkanen, et al.
Bone Marrow Transplantation|May 1, 1997
A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMTT Parkkali, R M Olander, T Ruutu, et al.
Bone Marrow Transplantation|May 16, 2000
Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipientsE Jantunen, A Piilonen, L Volin, et al.
Bone Marrow Transplantation|July 21, 2009
Invasive Aspergillus infections in allo-SCT recipients: environmental sampling, nasal and oral colonization and galactomannan testingA Nihtinen, V-J Anttila, M Richardson, et al.
Pageof 14